Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs

109Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims/hypothesis: The insulinotropic hormone, glucagon-like peptide-1 (GLP-1), is rapidly degraded in vivo as a result of the combination of extensive enzymatic degradation and renal extraction. The GLP-1 receptor agonist, exendin-4, has a longer duration of action, and has recently been approved as a new agent for the treatment of type 2 diabetes mellitus. Exendin-4 is less prone to enzymatic degradation, but it is still unclear what other factors contribute to the increased metabolic stability. Materials and methods: The overall metabolism of GLP-1 and exendin-4 was directly compared in anaesthetised pigs (n=9). Results: Metabolism of GLP-1 (C-terminal RIA; t1/2 2.0±0.2 min, metabolic clearance rate [MCR] 23.2±2.8 ml min -1 kg-1; N-terminal RIA; t1/2 1.5±0.2 min, MCR 88.1±10.6 ml min-1 kg-1) was significantly faster than the metabolism of exendin-4 (t1/2 22.0±2.1 min, p<0.0001; MCR 1.7±0.3 ml min-1 kg-1, p<0.01). Differences in arteriovenous concentrations revealed organ extraction of GLP-1 by the kidneys (C-terminal 56.6± 2.6%; N-terminal 48.3±5.9%), liver (N-terminal 41.4± 3.8%), and peripheral tissues (C-terminal 42.3±6.0%; N-terminal 33.0±7.8%), whereas organ extraction of exendin-4 was limited to the kidneys (21.3±4.9%). While the renal extraction of exendin-4 (6.9±2.5 pmol/min) did not differ significantly from the amount undergoing glomerular filtration (8.4±2.0 pmol/min), the renal extraction of C-terminal GLP-1 (9.0±1.1 pmol/min), exceeded the amount which could be accounted for by glomerular filtration (4.2±0.5 pmol/min, p<0.0005). Conclusions/interpretation: In addition to an increased resistance to enzymatic degradation, the increased stability of exendin-4 is the result of reduced differential organ extraction compared to GLP-1. The data suggest that in the anaesthetised pig, extraction occurs only in the kidney and can be fully accounted for by glomerular filtration. © Springer-Verlag 2006.

References Powered by Scopus

GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN

1630Citations
N/AReaders
Get full text

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: A parallel-group study

1230Citations
N/AReaders
Get full text

Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides

1199Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The physiology of glucagon-like peptide 1

2608Citations
N/AReaders
Get full text

The role of incretins in glucose homeostasis and diabetes treatment

688Citations
N/AReaders
Get full text

The incretin system and its role in type 2 diabetes mellitus

441Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Simonsen, L., Holst, J. J., & Deacon, C. F. (2006). Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs. Diabetologia, 49(4), 706–712. https://doi.org/10.1007/s00125-005-0128-9

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

69%

Researcher 8

23%

Professor / Associate Prof. 3

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 20

54%

Agricultural and Biological Sciences 9

24%

Pharmacology, Toxicology and Pharmaceut... 4

11%

Biochemistry, Genetics and Molecular Bi... 4

11%

Save time finding and organizing research with Mendeley

Sign up for free